about
Recent advances in gut nutrient chemosensingGlucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neuronsSustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.Glucose sensing in L cells: a primary cell study.Mechanisms responsible for excess weight loss after bariatric surgeryVertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats.Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.GLP-2 Prevents Intestinal Mucosal Atrophy and Improves Tissue Antioxidant Capacity in a Mouse Model of Total Parenteral Nutrition.Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.From diarrhea to obesity in prohormone convertase 1/3 deficiency: age-dependent clinical, pathologic, and enteroendocrine characteristics.Maternal ileal interposition surgery confers metabolic improvements to offspring independent of effects on maternal body weight in UCD-T2DM rats.Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed ratsThe role of gastrointestinal hormones in hepatic lipid metabolism.GLP-2 delays but does not prevent the onset of necrotizing enterocolitis in preterm pigs.Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways.Bile acids: short and long term effects in the intestine.The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease.Leaky gut and diabetes mellitus: what is the link?The "cryptic" mechanism of action of glucagon-like peptide-2.The enteric nervous system and neurogastroenterology.Review article: a comparison of glucagon-like peptides 1 and 2.Digestive physiology of the pig symposium: potential applications of knowledge of gut chemosensing in pig production.Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients.The pathophysiology of intestinal lipoprotein production.Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesisCOMPARATIVE GUT PHYSIOLOGY SYMPOSIUM: Comparative physiology of glucagon-like peptide-2: Implications and applications for production and health of ruminants.Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon.Complex dietary protein improves growth through a complex mechanism of intestinal peptide absorption and protein digestion.Glucagon like peptide-2 and neoplasia; a systematic review.Glucagon-like peptide-2 increases mesenteric blood flow in humans.Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.Increased GLP2R expression in gastric chief cells of patients with severe obesity regardless of diabetes status.Bile acids induce glucagon-like peptide 2 secretion with limited effects on intestinal adaptation in early weaned pigs.Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.Effect of supplementary calcium phosphate on plasma gastrointestinal hormones in a double-blind, placebo-controlled, cross-over human studyGlutamine Reduces Postprandial Glycemia and Augments the Glucagon-Like Peptide-1 Response in Type 2 Diabetes Patients
P2860
Q26830947-F7B5F376-9565-4E61-B1D8-E9F11573A8B2Q34215215-C94F5F02-0094-48CF-803B-05EA54E80D0EQ34425937-AEE03C85-51A9-42EE-81BE-9672A2717D21Q34726758-16BAF38B-FE48-4AB7-B690-E1387ABC5F49Q34890796-D89FD2A9-7C7F-4D67-8F29-F85A0CF96FECQ35529693-B099FE4F-155A-4835-807C-195EF4829989Q36113941-378B974F-49CF-45FF-A423-19231E5B1644Q36309586-2B83D30E-1519-44FA-9517-C6CC282D39D2Q36507488-732BEE6F-E77B-4FDE-A440-DF818EF8E70CQ36528419-BE6ADEED-A450-4BFF-9D8C-D1D13F2940D1Q36710038-7285A7C9-0CEF-4F38-827A-76D3B767B292Q37200132-F63EF3BE-5579-4DD5-88C6-BE805F053434Q37347948-CF66574D-C82E-4B30-B4EF-B920355E072BQ37372987-9903FAE0-BC6A-4D4C-AE50-A49290A0C552Q37422061-C00DF53D-9A6C-4580-BAB7-329FACFA288DQ37640700-4F467030-46A2-42AD-AA0F-8943810445BFQ37685841-A54AB152-0A7B-4EA8-9061-6B135CD47166Q37699321-83DFAE07-C6C9-438F-AEF6-E127B3F9E7E1Q37718243-9BB1FD24-1A2E-49BF-A2D8-7D1644595D06Q37840099-5B137BC3-A1AC-45BF-AFDD-A26AF35F6141Q37850489-35127756-84D5-4B51-8C10-3F544AA56563Q37870031-EF1511C5-BF55-4CE4-8BB7-6120309C2B3DQ37990818-412B6E18-B862-4B17-9B52-D43C2F5DDAE4Q38057350-4E31AFEC-407E-416F-8EBC-D5FFDA0590FDQ38081417-479D2376-D957-46FE-A6B2-944D9B55F4C7Q38123557-29A326D9-A81D-4414-878D-0AB8C1B6C9CBQ38410893-694624F7-CE34-415B-B478-E5089D7095FFQ41393541-5C458686-90C3-42EE-8119-7D9F1DAEA7D2Q42022343-630BC6A0-6D92-46C4-B151-ED5CBF8FD16FQ42477615-D0CBA554-B9DC-46B3-8EB9-088C628F2B22Q42938996-C9AA4970-902C-444D-9449-C534E9DD60A3Q47702740-BA018539-4D02-4901-94D0-BD2ED50A8FF7Q49901206-F2912713-1E3C-423E-808F-0BFD7E791ECBQ51437205-476363A3-C478-4862-8F49-B88CA14E8F92Q51836177-3455FA25-3240-4D72-97F9-4A70CF573418Q53405267-66A81B86-3BA8-4167-A60F-84FBCE8527BAQ54242842-EC319EBB-EACA-4B57-8B2A-B47BAE17849DQ55073464-C362D076-4BCE-42FD-A739-0EEDF0627C03Q57154246-1CBF3992-178F-41E7-931D-4D509A6D866DQ58448029-E903EA01-880C-45C9-8611-A3ECF6615D9B
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Glucagon-like Peptide-2.
@ast
Glucagon-like Peptide-2.
@en
type
label
Glucagon-like Peptide-2.
@ast
Glucagon-like Peptide-2.
@en
prefLabel
Glucagon-like Peptide-2.
@ast
Glucagon-like Peptide-2.
@en
P1476
Glucagon-like Peptide-2.
@en
P2093
Jennifer L Estall
P304
P356
10.1146/ANNUREV.NUTR.26.061505.111223
P407
P577
2006-01-01T00:00:00Z